CAMP-dependent protein kinase
From Proteopedia
(Difference between revisions)
Line 13: | Line 13: | ||
*<scene name='46/468128/Cv/6'>cAMP-binding site of catalytic subunit</scene> ([[4ntt]]).<ref>PMID:25077557</ref> | *<scene name='46/468128/Cv/6'>cAMP-binding site of catalytic subunit</scene> ([[4ntt]]).<ref>PMID:25077557</ref> | ||
*<scene name='46/468128/Cv/7'>Bovine PKA I-alpha ATP-binding pocket</scene> ([[4jv4]]).<ref>PMID:23978166</ref> | *<scene name='46/468128/Cv/7'>Bovine PKA I-alpha ATP-binding pocket</scene> ([[4jv4]]).<ref>PMID:23978166</ref> | ||
+ | |||
+ | ==3D structures of cAMP-dependent protein kinase== | ||
+ | [[CAMP-dependent protein kinase 3D structures]] | ||
+ | |||
</StructureSection> | </StructureSection> | ||
==3D structures of cAMP-dependent protein kinase== | ==3D structures of cAMP-dependent protein kinase== | ||
Line 27: | Line 31: | ||
**[[1fot]] - yPKA – yeast<br /> | **[[1fot]] - yPKA – yeast<br /> | ||
**[[4ae6]], [[4ae9]] – hPKA 2 – human<br /> | **[[4ae6]], [[4ae9]] – hPKA 2 – human<br /> | ||
+ | **[[6eh0]] – haPKA – hamster<br /> | ||
*PKA catalytic subunit binary complex | *PKA catalytic subunit binary complex | ||
- | **[[2cpk]], [[1ctp]], [[1fmo]], [[1l3r]], [[1xh4]], [[1xh5]], [[1xh6]], [[1xh7]], [[1xh8]], [[1xh9]], [[1xha]], [[3fjq]], [[4dg0]], [[4dg2]], [[4dh1]], [[4dh3]], [[4dh5]], [[4dh7]], [[4dh8]], [[4hpt]], [[4hpu]], [[4xw6]], [[4xw5]], [[4xw4]], [[3x2w]], [[3x2v]], [[3x2u]] – mPKA + peptide inhibitor<br /> | ||
- | **[[1q61]], [[1q62]], [[1smh]], [[2qur]], [[3qal]], [[3qam]], [[4dfx]], [[4dfz]], [[4dg3]] - mPKA (mutant) + peptide inhibitor<br /> | ||
- | **[[4iac]], [[4iad]], [[4iaf]], [[4iai]], [[4iak]], [[4iay]], [[4iaz]], [[4ib0]], [[4ib1]], [[4ib3]], [[4o22]] – mPKA + SP20 peptide<br /> | ||
**[[4ntt]] – mPKA (mutant) + ADP<br /> | **[[4ntt]] – mPKA (mutant) + ADP<br /> | ||
- | **[[2gfc]], [[3dnd]], [[3dne]], [[3kkv]], [[3zo1]], [[3zo2]], [[3zo3]], [[3zo4]], [[4ie9]], [[4ij9]], [[4yxs]], [[4yxr]] - bPKA + peptide inhibitor<br /> | ||
- | **[[4wih]], [[5lcp]], [[5lcq]], [[5lcr]], [[5lct]], [[5lcu]] - haPKA + peptide inhibitor – hamster<br /> | ||
**[[5n1f]], [[5n1g]], [[5n1h]], [[5n3g]], [[5n3h]], [[5n3i]], [[5n3j]], [[5n3k]], [[5n3l]], [[5n3m]], [[5n3n]], [[5n3o]], [[5n3p]], [[5n3q]], [[5n3r]], [[5n3s]], [[5n3t]] - haPKA + fragment molecule<br /> | **[[5n1f]], [[5n1g]], [[5n1h]], [[5n3g]], [[5n3h]], [[5n3i]], [[5n3j]], [[5n3k]], [[5n3l]], [[5n3m]], [[5n3n]], [[5n3o]], [[5n3p]], [[5n3q]], [[5n3r]], [[5n3s]], [[5n3t]] - haPKA + fragment molecule<br /> | ||
- | **[[ | + | **[[6em2]] - haPKA + fasudil<br /> |
- | + | **[[6c0u]] - hPKA + inhibitor<br /> | |
- | **[[ | + | |
- | + | ||
**[[3bwj]] - bPKA + bisubstrate inhibitor<br /> | **[[3bwj]] - bPKA + bisubstrate inhibitor<br /> | ||
**[[3agl]], [[3agm]] – hPKA + bisubstrate inhibitor<br /> | **[[3agl]], [[3agm]] – hPKA + bisubstrate inhibitor<br /> | ||
Line 46: | Line 44: | ||
**[[3o7l]] – mPKA + phospholamban<br /> | **[[3o7l]] – mPKA + phospholamban<br /> | ||
**[[1bx6]], [[1re8]], [[1rej]], [[1rek]] - mPKA + balanol analog<br /> | **[[1bx6]], [[1re8]], [[1rej]], [[1rek]] - mPKA + balanol analog<br /> | ||
- | **[[1cdk]] - pPKA + peptide inhibitor – pig<br /> | ||
**[[1szm]] - bPKA + bisindolymaleimide<br /> | **[[1szm]] - bPKA + bisindolymaleimide<br /> | ||
**[[3ag9]] - bPKA + inhibitor<br /> | **[[3ag9]] - bPKA + inhibitor<br /> | ||
+ | |||
+ | *PKA catalytic subunit binary complex with peptide inhibitor | ||
+ | |||
+ | **[[2cpk]], [[1ctp]], [[1fmo]], [[1l3r]], [[1xh4]], [[1xh5]], [[1xh6]], [[1xh7]], [[1xh8]], [[1xh9]], [[1xha]], [[3fjq]], [[4dg0]], [[4dg2]], [[4dh1]], [[4dh3]], [[4dh5]], [[4dh7]], [[4dh8]], [[4hpt]], [[4hpu]], [[4xw6]], [[4xw5]], [[4xw4]], [[3x2w]], [[3x2v]], [[3x2u]] – mPKA + peptide inhibitor<br /> | ||
+ | **[[1q61]], [[1q62]], [[1smh]], [[2qur]], [[3qal]], [[3qam]], [[4dfx]], [[4dfz]], [[4dg3]] - mPKA (mutant) + peptide inhibitor<br /> | ||
+ | **[[4iac]], [[4iad]], [[4iaf]], [[4iai]], [[4iak]], [[4iay]], [[4iaz]], [[4ib0]], **[[4ib1]], [[4ib3]], [[4o22]] – mPKA + SP20 peptide<br /> | ||
+ | **[[2gfc]], [[3dnd]], [[3dne]], [[3kkv]], [[3zo1]], [[3zo2]], [[3zo3]], [[3zo4]], [[4ie9]], [[4ij9]], [[4yxs]], [[4yxr]] - bPKA + peptide inhibitor<br /> | ||
+ | **[[4wih]], [[5lcp]], [[5lcq]], [[5lcr]], [[5lct]], [[5lcu]], [[5m0u]] - haPKA + peptide inhibitor <br /> | ||
+ | **[[2gng]], [[4axa]], [[4c33]], [[4c34]], [[4c35]], [[4c36]], [[4c37]], [[4c38]] - bPKA (mutant) + peptide inhibitor<br /> | ||
+ | **[[3mvj]], [[3oog]], [[3poo]], [[3vqh]], [[5j5x]], [[5izj]], [[5izf]], [[5bx7]], [[5bx6]], [[4ujb]], [[4uja]], [[4uj9]], [[4uj2]], [[4uj1]] - hPKA + peptide inhibitor<br /> | ||
+ | **[[4z84]], [[4z83]] - hPKA (mutant) + peptide inhibitor<br /> | ||
+ | **[[4wb5]], [[4wb6]], [[4wb8]] – mPKA (mutant) + PKI peptide<br /> | ||
+ | **[[1cdk]] - pPKA + peptide inhibitor – pig<br /> | ||
*PKA catalytic subunit ternary complex | *PKA catalytic subunit ternary complex | ||
**[[1apm]], [[1jlu]] - mPKA + detergent + peptide inhibitor<br /> | **[[1apm]], [[1jlu]] - mPKA + detergent + peptide inhibitor<br /> | ||
- | **[[1jbp]] - mPKA + detergent + peptide inhibitor + ADP<br /> | ||
- | **[[1rdq]] - mPKA + peptide inhibitor + ADP + ATP<br /> | ||
- | **[[4o21]] - mPKA + peptide inhibitor + ATP-γ-S<br /> | ||
- | **[[1atp]] - mPKA + peptide inhibitor + Mn-ATP<br /> | ||
**[[2erz]] - mPKA + peptide inhibitor + hydroxyfasudil<br /> | **[[2erz]] - mPKA + peptide inhibitor + hydroxyfasudil<br /> | ||
**[[1cmk]] - pPKA + peptide inhibitor + myristic acid<br /> | **[[1cmk]] - pPKA + peptide inhibitor + myristic acid<br /> | ||
**[[1stc]] - bPKA + peptide inhibitor + saturosporine<br /> | **[[1stc]] - bPKA + peptide inhibitor + saturosporine<br /> | ||
**[[2gnh]], [[2gni]], [[2gnj]], [[2gnl]], [[2jdv]], [[2uvx]], [[2uvy]], [[2uvz]], [[2uw0]], [[2uw3]], [[2uw4]], [[2uw5]], [[2uw6]], [[2uw7]], [[2uw8]], [[2vnw]], [[2vny]], [[2vo0]], [[2vo3]], [[2vo6]], [[2vo7]] - bPKA (mutant) + peptide inhibitor + inhibitor<br /> | **[[2gnh]], [[2gni]], [[2gnj]], [[2gnl]], [[2jdv]], [[2uvx]], [[2uvy]], [[2uvz]], [[2uw0]], [[2uw3]], [[2uw4]], [[2uw5]], [[2uw6]], [[2uw7]], [[2uw8]], [[2vnw]], [[2vny]], [[2vo0]], [[2vo3]], [[2vo6]], [[2vo7]] - bPKA (mutant) + peptide inhibitor + inhibitor<br /> | ||
- | **[[1ydr]], [[1yds]], [[1ydt]] - bPKA + peptide inhibitor + inhibitor<br /> | + | **[[1ydr]], [[1yds]], [[1ydt]], [[2c1a]], [[2c1b]], [[2oh0]], [[2ojf]], [[2uzt]], [[2uzu]], [[2uzv]], [[2uzw]], [[2f7e]], [[2f7x]], [[2f7z]], [[2jds]], [[5vib]] - bPKA + peptide inhibitor + inhibitor<br /> |
+ | **[[2jdt]], [[5vi9]] - bPKA (mutant) + peptide inhibitor + inhibitor<br /> | ||
+ | **[[3e8c]], [[3e8e]] - bPKA catalytic subunit + peptide inhibitor + ATP-competitive inhibitor<br /> | ||
+ | **[[1q8t]], [[1q8u]], [[1q8w]]- bPKA + peptide inhibitor + rho-kinase inhibitor<br /> | ||
+ | **[[2gnf]] - bPKA (mutant) + peptide inhibitor + rho-kinase inhibitor<br /> | ||
+ | **[[1sve]], [[1svg]], [[1svh]], [[1veb]] - bPKA + detergent + peptide inhibitor + azepane derivative<br /> | ||
**[[2gu8]], [[3l9l]], [[3ovv]], [[3owp]], [[3oxt]], [[3p0m]], [[5uzk]] - hPKA catalytic subunit + peptide inhibitor + inhibitor<br /> | **[[2gu8]], [[3l9l]], [[3ovv]], [[3owp]], [[3oxt]], [[3p0m]], [[5uzk]] - hPKA catalytic subunit + peptide inhibitor + inhibitor<br /> | ||
**[[3nx8]] - hPKA catalytic subunit + peptide inhibitor + phenol<br /> | **[[3nx8]] - hPKA catalytic subunit + peptide inhibitor + phenol<br /> | ||
Line 67: | Line 78: | ||
**[[3wyg]] – hPKA + GSP1P + exportin<br /> | **[[3wyg]] – hPKA + GSP1P + exportin<br /> | ||
**[[3ow3]] - mPKA catalytic subunit + peptide inhibitor + inhibitor<br /> | **[[3ow3]] - mPKA catalytic subunit + peptide inhibitor + inhibitor<br /> | ||
- | **[[ | + | **[[5mhi]], [[5n1d]], [[5n1e]], [[5n1k]], [[5n1l]], [[5n1m]], [[5n1n]], [[5n1o]], [[5n32]], [[5n33]], [[5n36]], [[5n37]], [[5n39]], [[5n3a]], [[5n3b]], [[5n3c]], [[5n3d]], [[5n3e]], [[5n3f]], [[5n7p]], [[5n7u]] - haPKA + peptide inhibitor + fragment molecule<br /> |
- | **[[ | + | **[[6f14]], [[6frx]], [[6erv]], [[6eru]], [[6ert]], [[6eme]], [[6emd]], [[6emc]], [[6eh3]], [[6egw]], [[5ous]], [[5ouc]], [[5oua]], [[5otg]], [[5ot3]], [[5ol3]], [[5ok3]], [[5o5m]], [[5o0e]], [[5nw8]], [[5ntj]] - haPKA + peptide inhibitor + inhibitor<br /> |
+ | **[[6erw]], [[6ers]], [[6emb]], [[5m75]], [[5m71]], [[5m6y]], [[5m6v]], [[5m0l]], [[5m0c]], [[5m0b]] - haPKA + peptide inhibitor + fasudil derivative<br /> | ||
+ | |||
+ | *PKA catalytic subunit ternary complex with nucleotide | ||
+ | |||
+ | **[[1jbp]] - mPKA + detergent + peptide inhibitor + ADP<br /> | ||
+ | **[[1rdq]] - mPKA + peptide inhibitor + ADP + ATP<br /> | ||
+ | **[[4o21]] - mPKA + peptide inhibitor + ATP-G-S<br /> | ||
+ | **[[1atp]] - mPKA + peptide inhibitor + Mn-ATP<br /> | ||
**[[1q24]] - bPKA + peptide inhibitor + Mg-ATP<br /> | **[[1q24]] - bPKA + peptide inhibitor + Mg-ATP<br /> | ||
- | **[[ | + | **[[6ema]] - haPKA + peptide inhibitor + inhibitor + ATP<br /> |
- | + | **[[6e21]] - mPKA + peptide inhibitor + ADP<br /> | |
- | **[[ | + | **[[6em7]], [[6em6]] - haPKA + peptide inhibitor + inhibitor + ADP<br /> |
- | + | **[[6eh2]] - haPKA + peptide inhibitor + inhibitor + AMP<br /> | |
- | **[[ | + | **[[6esa]] - haPKA + peptide inhibitor + ribose + AMP<br /> |
- | + | ||
- | **[[ | + | |
- | + | ||
- | **[[ | + | |
- | + | ||
- | + | ||
*PKA regulatory subunit | *PKA regulatory subunit | ||
Line 114: | Line 128: | ||
*PKA catalytic and regulatory subunits | *PKA catalytic and regulatory subunits | ||
+ | **[[6bys]] – hPKA<br /> | ||
**[[2qvs]], [[3idb]], [[3idc]], [[3pvb]], [[4din]], [[4x6q]], [[4wbb]] - mPKA <br /> | **[[2qvs]], [[3idb]], [[3idc]], [[3pvb]], [[4din]], [[4x6q]], [[4wbb]] - mPKA <br /> | ||
**[[3fhi]], [[2qcs]], [[3tnp]], [[3tnq]], [[4x6r]] - mPKA (mutant) <br /> | **[[3fhi]], [[2qcs]], [[3tnp]], [[3tnq]], [[4x6r]] - mPKA (mutant) <br /> |
Revision as of 08:52, 22 April 2019
|
3D structures of cAMP-dependent protein kinase
Updated on 22-April-2019
References
- ↑ Bastidas AC, Wu J, Taylor SS. Molecular Features of Product Release for the PKA Catalytic Cycle. Biochemistry. 2014 Aug 8. PMID:25077557 doi:http://dx.doi.org/10.1021/bi500684c
- ↑ Brown SH, Cheng CY, Saldanha SA, Wu J, Cottam HB, Sankaran B, Taylor SS. Implementing Fluorescence Anisotropy Screening and Crystallographic Analysis to Define PKA Isoform-Selective Activation by cAMP Analogs. ACS Chem Biol. 2013 Sep 10. PMID:23978166 doi:10.1021/cb400247t